These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 753282)

  • 21. Abrogation of graft-vs.-leukemia activity after depletion of CD3+ T cells in a murine model of MHC-matched peripheral blood progenitor cell transplantation (PBPCT).
    Uharek L; Glass B; Zeis M; Dreger P; Steinmann J; Löffler H; Schmitz N
    Exp Hematol; 1998 Feb; 26(2):93-9. PubMed ID: 9472798
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro generation of secondary cell-mediated cytotoxic response against a syngeneic Gross virus-induced lymphoma in rats.
    Glaser M; Bonnard GD; Herberman RB
    J Immunol; 1976 Feb; 116(2):430-6. PubMed ID: 1082456
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Leukemia virus-induced immunosuppression. X. Depression of T cell-mediated cytotoxicity after infection of mice with Friend leukemia virus.
    Mortensen RF; Ceglowski WS; Friedman H
    J Immunol; 1974 Jun; 112(6):2077-86. PubMed ID: 4207729
    [No Abstract]   [Full Text] [Related]  

  • 24. Characterization and functional properties of tumor cell lines in accessory cell replacement assays.
    Walker EB; Lanier LL; Warner NL
    J Immunol; 1982 Feb; 128(2):852-9. PubMed ID: 7033383
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transfer to cyclophosphamide-treated mice of natural killer (NK) cells and in vivo natural reactivity against tumors.
    Riccardi C; Barlozzari T; Santoni A; Herberman RB; Cesarini C
    J Immunol; 1981 Apr; 126(4):1284-9. PubMed ID: 7204966
    [No Abstract]   [Full Text] [Related]  

  • 26. Drug-mediated increase of tumor immunogenicity in vivo for a new approach to experimental cancer immunotherapy.
    Giampietri A; Bonmassar A; Puccetti P; Circolo A; Goldin A; Bonmassar E
    Cancer Res; 1981 Feb; 41(2):681-7. PubMed ID: 7448813
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [In vitro cytolysis mediated by NK effectors: modification of the susceptibility of the target cell by in vivo treatment with DTIC].
    Migliorati G; Romani L; Fioretti MC
    Boll Soc Ital Biol Sper; 1981 May; 57(9):1024-30. PubMed ID: 7284118
    [TBL] [Abstract][Full Text] [Related]  

  • 28. L3T4+ T cells regulate Abelson virus-induced lymphomagenesis.
    Infante AJ; Boulware S; Cagle M
    J Immunol; 1988 Apr; 140(7):2462-5. PubMed ID: 2965186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Temperature control of lymphocyte-mediated cytotoxicity in vitro.
    Berke G; Sullivan KA
    Transplant Proc; 1973 Mar; 5(1):421-3. PubMed ID: 4695950
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effect of interferon on the immune response of mice to immunization with the cells of transplantable leukemias and sarkomas].
    Skurkovich SV; Ol'shanskaia NV; Kalinina IA; Klinova EG; Eremkina EI
    Vopr Onkol; 1977; 23(9):44-50. PubMed ID: 910422
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specificity of cytolytic T cells directed against AKR/Gross virus-induced syngeneic leukemias: antibodies directed against H-2K, but not against viral proteins, inhibit lysis.
    Green WR; Nowinski RC; Henney CS
    J Immunol; 1980 Aug; 125(2):647-55. PubMed ID: 6156211
    [No Abstract]   [Full Text] [Related]  

  • 32. Lectin-induced nonlethal adhesions between cytolytic T lymphocytes and antigenically unrecognizable tumor cells and nonspecific "triggering" of cytolysis.
    Parker WL; Martz E
    J Immunol; 1980 Jan; 124(1):25-35. PubMed ID: 6765968
    [No Abstract]   [Full Text] [Related]  

  • 33. Functional efficiency of antitumor cytotoxic lymphoid cells.
    Wunderlich JR; Martin WJ; Macdonald J
    Isr J Med Sci; 1973 Mar; 9(3):317-23. PubMed ID: 4710039
    [No Abstract]   [Full Text] [Related]  

  • 34. Macrophage-mediated natural cytotoxicity of dimethyl sulfoxide-treated Friend erythroleukemia cells.
    Hsu KH; Friedman H
    J Natl Cancer Inst; 1985 Jul; 75(1):105-10. PubMed ID: 3859684
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of a cytophilic factor from challenged immune peritoneal lymphocytes in specific macrophage cytotoxicity.
    Pels E; den Otter W
    Cancer Res; 1974 Nov; 34(11):3089-94. PubMed ID: 4423930
    [No Abstract]   [Full Text] [Related]  

  • 36. Variants from a MLV-induced lymphoma selected for decreased sensitivity to NK lysis.
    Grönberg A; Kiessling R; Eriksson E; Hansson M
    J Immunol; 1981 Nov; 127(5):1734-9. PubMed ID: 6975295
    [No Abstract]   [Full Text] [Related]  

  • 37. Antigenic modulation as a mechanism for tumor escape from immune destruction: identification of modulation-positive and modulation-negative mouse lymphomas with xenoantisera to murine leukemia virus gp70.
    Stackpole CW; Cremona P; Leonard C; Stremmel P
    J Immunol; 1980 Oct; 125(4):1715-23. PubMed ID: 6251136
    [No Abstract]   [Full Text] [Related]  

  • 38. Function and role of peritoneal macrophages in experimental leukaemia.
    Thi Phi Phi P; Nedelkova M; Serafimov-Dimitrov V
    Haematologia (Budap); 1981; 14(1):29-38. PubMed ID: 7250816
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transplantability and sensitivity to natural killer cells of aclarubicin-resistant murine lymphoma.
    Sugimoto Y; Hirakawa Y; Tanaka N; Tahara M; Sato I; Nishimura T; Suzuki H; Tanaka N
    Cancer Res; 1986 Nov; 46(11):5646-8. PubMed ID: 3463416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunoregulatory circuit among macrophage subsets for T cell-mediated cytotoxic response to tumor cells.
    Ting CC; Rodrigues D
    J Immunol; 1980 Mar; 124(3):1039-44. PubMed ID: 6444645
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.